Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Mar 1:7:49.
doi: 10.4103/2008-7802.177895. eCollection 2016.

Calcium-Vitamin D Co-supplementation Affects Metabolic Profiles, but not Pregnancy Outcomes, in Healthy Pregnant Women

Zatollah Asemi  1 , Mansooreh Samimi  2 , Mehrnush Amiri Siavashani  3 , Maryam Mazloomi  4 , Zohreh Tabassi  2 , Maryam Karamali  4 , Mehri Jamilian  5 , Ahmad Esmaillzadeh  6
Affiliations

Calcium-Vitamin D Co-supplementation Affects Metabolic Profiles, but not Pregnancy Outcomes, in Healthy Pregnant Women

Zatollah Asemi et al. Int J Prev Med. .

Abstract

Background: Pregnancy is associated with unfavorable metabolic profile, which might in turn result in adverse pregnancy outcomes. The current study was designed to evaluate the effects of calcium plus Vitamin D administration on metabolic status and pregnancy outcomes in healthy pregnant women.

Methods: This randomized double-blind placebo-controlled clinical trial was performed among 42 pregnant women aged 18-40 years who were at week 25 of gestation. Subjects were randomly allocated to consume either 500 mg calcium-200 IU cholecalciferol supplements (n = 21) or placebo (n = 21) for 9 weeks. Blood samples were obtained at the onset of the study and after 9-week trial to determine related markers. Post-delivery, the newborn's weight, length, and head circumference were measured during the first 24 h after birth.

Results: Consumption of calcium-Vitamin D co-supplements resulted in a significant reduction of serum high-sensitivity C-reactive protein levels compared with placebo (-1856.8 ± 2657.7 vs. 707.1 ± 3139.4 μg/mL, P = 0.006). We also found a significant elevation of plasma total antioxidant capacity (89.3 ± 118.0 vs. -9.4 ± 164.9 mmol/L, P = 0.03), serum 25-hydroxyvitamin D (2.5 ± 3.5 vs. -1.7 ± 1.7 ng/mL, P < 0.0001), and calcium levels (0.6 ± 0.6 vs. -0.1 ± 0.4 mg/dL, P < 0.0001). The supplementation led to a significant decrease in diastolic blood pressure (-1.9 ± 8.3 vs. 3.1 ± 5.2 mmHg, P = 0.02) compared with placebo. No significant effect of calcium-Vitamin D co-supplements was seen on other metabolic profiles. We saw no significant change of the co-supplementation on pregnancy outcomes as well.

Conclusions: Although calcium-Vitamin D co-supplementation for 9 weeks in pregnant women resulted in improved metabolic profiles, it did not affect pregnancy outcomes.

Keywords: Calcium-Vitamin D supplementation; high sensitivity C-reactive protein; insulin resistance; oxidative stress; pregnancy outcome.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Consort 2010 flow diagram of subject enrollment, allocation, follow-up, and analysis
See this image and copyright information in PMC

References

    1. Ghojazadeh M, Azami-Aghdash S, Mohammadi M, Vosoogh S, Mohammadi S, Naghavi-Behzad M. Prognostic risk factors for early diagnosing of preeclampsia in nulliparas. Niger Med J. 2013;54:344–8. - PMC - PubMed
    1. Asemi Z, Karamali M, Esmaillzadeh A. Effects of calcium-Vitamin D co-supplementation on glycaemic control, inflammation and oxidative stress in gestational diabetes: A randomised placebo-controlled trial. Diabetologia. 2014;57:1798–806. - PubMed
    1. Perez-Ferre N, Torrejon MJ, Fuentes M, Fernandez MD, Ramos A, Bordiu E, et al. Association of low serum 25-hydroxyvitamin D levels in pregnancy with glucose homeostasis and obstetric and newborn outcomes. Endocr Pract. 2012;18:676–84. - PubMed
    1. Asemi Z, Taghizadeh M, Sarahroodi S, Jazayeri S, Tabasi Z, Seyyedi F. Assessment of the relationship of Vitamin D with serum antioxidant Vitamins E and A and their deficiencies in Iranian pregnant women. Saudi Med J. 2010;31:1119–23. - PubMed
    1. Jahromi AS, Zareian P, Madani A. Association of insulin resistance with serum interleukin-6 and TNF-a levels during normal pregnancy. Biomark Insights. 2011;6:1–6. - PMC - PubMed